메뉴 건너뛰기




Volumn 2, Issue 8, 2012, Pages 640-644

Science behind cisplatin-induced nephrotoxicity in humans: A clinical study

Author keywords

Cisplatin; Creatinine; Electrolyte imbalance; Hypocalcaemia; Hypomagnesia

Indexed keywords

CISPLATIN; CREATININE; DEXAMETHASONE; ELECTROLYTE; FUROSEMIDE; GRANISETRON; MANNITOL; MULTIVITAMIN; NITROGEN; POTASSIUM; RANITIDINE; SODIUM; UREA; ANTINEOPLASTIC AGENT;

EID: 84860617709     PISSN: 22211691     EISSN: None     Source Type: Journal    
DOI: 10.1016/S2221-1691(12)60112-9     Document Type: Article
Times cited : (41)

References (10)
  • 3
    • 77953523701 scopus 로고    scopus 로고
    • Overview and frontier for the development of metallopharmaceutics
    • Hiromu S Overview and frontier for the development of metallopharmaceutics. J Health Sci 2010, 56(2):129-143.
    • (2010) J Health Sci , vol.56 , Issue.2 , pp. 129-143
    • Hiromu, S.1
  • 4
    • 79960803462 scopus 로고    scopus 로고
    • Effectiveness of carnosine on disturbed electrolytes homeostasis induced by cisplatin
    • Shafaq N, Tabassum M Effectiveness of carnosine on disturbed electrolytes homeostasis induced by cisplatin. Afr J Biotechnol 2011, 10(37):7286-7293.
    • (2011) Afr J Biotechnol , vol.10 , Issue.37 , pp. 7286-7293
    • Shafaq, N.1    Tabassum, M.2
  • 5
    • 55249106406 scopus 로고    scopus 로고
    • Renal protection with magnesium subcarbonate and magnesium sulphate in patients with epithelial ovarian cancer after cisplatin and paclitaxel chemotherapy: A randomised phase II study
    • Lubomir B, Gabriel W, Agnieszka GB, Agnieszka S, Katarzyna SW, Cezary S Renal protection with magnesium subcarbonate and magnesium sulphate in patients with epithelial ovarian cancer after cisplatin and paclitaxel chemotherapy: A randomised phase II study. Eur J Cancer 2008, 44(17):2608-2614.
    • (2008) Eur J Cancer , vol.44 , Issue.17 , pp. 2608-2614
    • Lubomir, B.1    Gabriel, W.2    Agnieszka, G.B.3    Agnieszka, S.4    Katarzyna, S.W.5    Cezary, S.6
  • 6
    • 84860644308 scopus 로고    scopus 로고
    • Evaluation of intravenous magnesium supplementation as prophylaxis for cisplatin-induced hypomagnesemia
    • Kazem A, Mehdi ST, Marjaneh M Evaluation of intravenous magnesium supplementation as prophylaxis for cisplatin-induced hypomagnesemia. Middle East J Cancer 2010, 1(3):109-114.
    • (2010) Middle East J Cancer , vol.1 , Issue.3 , pp. 109-114
    • Kazem, A.1    Mehdi, S.T.2    Marjaneh, M.3
  • 7
    • 74249085769 scopus 로고    scopus 로고
    • Serum potassium, calcium and magnesium in patients receiving ESHAP chemotherapy for relapsed lymphomas
    • Zekri J, Cheah NL, Evans L, Hancock B Serum potassium, calcium and magnesium in patients receiving ESHAP chemotherapy for relapsed lymphomas. J R Coll Physicians Edinb 2009, 39:301-306.
    • (2009) J R Coll Physicians Edinb , vol.39 , pp. 301-306
    • Zekri, J.1    Cheah, N.L.2    Evans, L.3    Hancock, B.4
  • 9
    • 77951692595 scopus 로고    scopus 로고
    • Adverse drug reaction profile of cisplatin-based chemotherapy regimen in a tertiary care hospital in India: An evaluative study
    • Surinder A, Balamurugan N, Gunaseelan K, Shasid A, Reddy KS, Adithan C Adverse drug reaction profile of cisplatin-based chemotherapy regimen in a tertiary care hospital in India: An evaluative study. Indian J Pharmacol 2010, 42(1):40-43.
    • (2010) Indian J Pharmacol , vol.42 , Issue.1 , pp. 40-43
    • Surinder, A.1    Balamurugan, N.2    Gunaseelan, K.3    Shasid, A.4    Reddy, K.S.5    Adithan, C.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.